GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Bioventix BVXP.L · GBp

Health Care · LSE · 🇬🇧 United Kingdom

Compare

1,925.00p

-1.28%

Close of 9 Nov 2026, in pence

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in GBP, from our data supplier.

FY2026

Revenue

£13.0m

FY2017FY2026

Net income

£7.6m

FY2017FY2026

Free cash flow

£8.0m

FY2017FY2026

Shareholders' equity

£11.4m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue£13.0m£13.1m£13.6m£12.8m£11.7m£10.9m£10.3m£9.3m£8.8m£7.2m
Gross profit£11.8m£11.9m£12.7m£11.9m£10.9m£10.0m£9.4m£8.4m£8.2m£6.8m
Research and development£1.5m£1.5m£999,418£1.2m£975,317£1.2m£1.2m£1.1m£868,515£764,480
Operating income£9.7m£9.9m£10.6m£10.0m£9.3m£8.1m£8.0m£7.0m£6.9m£5.7m
Net income£7.6m£7.6m£8.1m£8.4m£7.7m£6.7m£7.2m£5.9m£5.7m£4.9m
Diluted earnings per share1.431.431.531.581.461.281.371.121.080.94

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets£12.8m£12.9m£13.7m£13.3m£13.1m£12.9m£13.3m£11.6m£11.9m£10.4m
Cash and short-term investments£5.3m£5.1m£6.0m£5.7m£6.1m£6.5m£8.1m£6.5m£7.0m£6.2m
Total liabilities£1.4m£1.3m£1.7m£1.2m£1.3m£1.1m£778,868£787,427£864,657£236,058
Debt£10,970—————————
Shareholders' equity£11.4m£11.6m£12.0m£12.1m£11.8m£11.8m£12.5m£10.8m£11.0m£10.1m
Shares outstanding5m5m5m5m5m5m5m5m5m5m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations£8.1m£7.0m£8.3m£7.9m£7.6m£6.4m£7.7m£5.9m£5.9m£4.0m
Capital spending−£71,600−£19,189−£15,907−£10,583−£11,756−£260,326−£339,620−£84,518−£107,591−£21,703
Free cash flow£8.0m£7.0m£8.3m£7.9m£7.5m£6.1m£7.4m£5.8m£5.8m£3.9m
Dividends paid−£7.8m−£8.2m−£8.2m−£8.4m−£7.9m−£7.7m−£6.5m−£6.2m−£4.9m−£3.4m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Mar 2023
Revenue£6.8m£6.2m£6.4m£6.7m£6.9m£6.7m£6.9m£3.5m
Gross profit£6.2m£5.6m£5.9m£5.9m£6.4m£6.2m£6.5m£3.3m
Operating income£5.2m£4.6m£4.9m£4.9m£5.5m£5.1m£5.6m£2.8m
Net income£4.0m£3.6m£3.8m£3.8m£4.1m£4.0m£4.6m£2.3m
Diluted earnings per share0.750.680.720.710.770.760.880.44
Cash from operations£3.0m£4.0m£3.0m£3.0m£4.0m£4.0m£3.0m—
Total assets£12.8m£13.0m£12.9m£13.0m£13.7m£13.1m£13.3m£13.3m
Cash and short-term investments£5.3m£5.3m£5.1m£5.1m£6.0m£5.5m£5.7m£5.7m
Debt£3,816———————
Shareholders' equity£11.4m£11.0m£11.6m£11.3m£12.0m£11.4m£12.1m£12.1m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue0.4%3.5%8.9%
Operating income-1.0%3.8%9.0%
Net income-3.1%2.5%8.1%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin90.9%91.9%91.9%91.9%
Operating margin75.3%76.7%76.7%76.9%
Net margin58.3%60.3%61.3%63.0%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings13.413.320.827.227.426.632.029.528.326.2
Price to sales7.97.712.417.817.916.422.418.618.317.8

Dividends and splits

Per share, in the currency the company pays

Paid for 12 years. Last went ex-dividend on 6 Nov 2025.

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Paid in the year0.801.571.581.360.900.950.790.66

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.